Sonosensitizers are specialized compounds that enhance the efficacy of sonodynamic therapy (SDT), a non-invasive treatment modality for cancer. These compounds are designed to increase the sensitivity of cancer cells to ultrasound waves, which are used to induce cytotoxic effects. The mechanism involves the generation of reactive oxygen species (ROS) that can damage cellular components, ultimately leading to cell death.
